Both in Pharmaceuticals
Lantern Pharma vs Actuate Therapeutics
Over the past year LTRN returned −80.6% and ACTU returned −94.3%; their daily moves had a correlation of 0.12.
LTRN −80.6% ACTU −94.3%Growth of $1, one year, split-adjusted
| Metric | LTRN | ACTU |
|---|---|---|
| Price | $0.7737 | $0.3833 |
| Market cap | $11.6M | $9.2M |
| Today | +20.89% | −4.06% |
| 1 month | −28.7% | −44.1% |
| 6 months | −60.9% | −86.7% |
| Year to date | −74.5% | −93.7% |
| 1 year | −80.9% | −94.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.4M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 91.0% | 162.7% |
| Short % of float | 3.4% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).